Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Nagler, M; Angelillo-Scherrer, A; Méan, M; Limacher, A; Abbal, C; Righini, M; Beer, J H; Osterwalder, J; Frauchiger, B; Aschwanden, M; Matter, C M; Kucher, N; Cornuz, J; Banyai, M; Husmann, M; Staub, D; Mazzolai, L; Hugli, O; Rodondi, N; Aujesky, D (2017). Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of Thrombosis and Haemostasis, 15(11):2165-2175.

Studt, J D; Alberio, L; Angelillo-Scherrer, A; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of Thrombosis and Haemostasis, 15(8):1576-1583.

Zwierzina, D; Limacher, A; Méan, M; Righini, M; Jaeger, K; Beer, H-J; Frauchiger, B; Osterwalder, J; Kucher, N; Matter, C M; Banyai, M; Angelillo-Scherrer, A; Lämmle, B; Egloff, M; Aschwanden, M; Mazzolai, L; Hugli, O; Husmann, M; Bounameaux, H; Cornuz, J; Rodondi, N; Aujesky, D (2012). Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism. Journal of Thrombosis and Haemostasis, 10(11):2270-2276.

Asmis, L M; Alberio, L; Angelillo-Scherrer, A; Korte, W; Mendez, A; Reber, G; Seifert, Burkhardt; Stricker, H; Tsakiris, D A; Wuillemin, W A (2012). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis Research, 129(4):492-498.

This list was generated on Sat Sep 21 22:03:33 2019 CEST.